NCT03887273
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +17 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Clinical trial condition
Demyelinating Autoimmune Diseases, CNS
Explore clinical trials studying Demyelinating Autoimmune Diseases, CNS. Study availability and eligibility vary by location and protocol.
2,726 public trials
402 recruiting studies
Demyelinating Autoimmune Diseases, CNS trial results
NCT07085507
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- CMAX Adelaide, South Australia, Australia
NCT06680037
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, B-cell Mediated Autoimmune Disorders, +28 more
- Locations
-
- TG Therapeutics Investigational Trial Site La Jolla, California, United States
- TG Therapeutics Investigational Trial Site Ann Arbor, Michigan, United States
- TG Therapeutics Investigational Trial Site Omaha, Nebraska, United States
- TG Therapeutics Investigational Trial Site New York, United States
NCT07282574
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- Southern Neurology Kogarah, New South Wales, Australia
- John Hunter Hospital New Lambton Heights, New South Wales, Australia
- Box Hill Hospital Box Hill, Victoria, Australia
- Austin Health Heidelberg, Victoria, Australia
Recruiting
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
NCT06136728
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- MGH Institute of Health Professions Boston, Massachusetts, United States
NCT06433752
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- TG Therapeutics Investigational Trial Site Birmingham, Alabama, United States
- TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
- TG Therapeutics Investigational Trial Site Mobile, Alabama, United States
- TG Therapeutics Investigational Trial Site Gilbert, Arizona, United States
Recruiting
Ocrevus Zunovo for MS: Mixed Methods
NCT07710105
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Northwestern Memorial Hospital Chicago, Illinois, United States
Recruiting
A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
NCT06143514
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- PROVIDE Virtual Research Coordination Center San Francisco, California, United States
- PROVIDE Virtual Research Coordination Center Smyrna, Georgia, United States
- TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
- PROVIDE Virtual Research Coordination Center Wilmington, North Carolina, United States
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- TG Therapeutics Investigational Trial Site Bihać, Bosnia and Herzegovina
- TG Therapeutics Investigational Trial Site Sarajevo, Bosnia and Herzegovina
- TG Therapeutics Investigational Trial Site Tuzla, Bosnia and Herzegovina
- TG Therapeutics Investigational Trial Site Zenica, Bosnia and Herzegovina
NCT06433765
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- BRIUMVI® Pregnancy Registry Virtual Research Coordination Center Wilmington, North Carolina, United States